CGPA and Biosimilars Canada welcome the Government of Quebec’s initiative to improve access to cost-saving medicines
10 October 2025
The CGPA and its Biosimilars Canada division welcome the Ontario government’s announcement of a $146 million investment in the next phase of its Life Sciences Strategy to help position the province as a global leader in life sciences.